{"id":47982,"date":"2022-09-05T19:01:55","date_gmt":"2022-09-05T17:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/"},"modified":"2022-09-05T19:01:55","modified_gmt":"2022-09-05T17:01:55","slug":"medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/","title":{"rendered":"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB)"},"content":{"rendered":"
\n

MONTPELLIER, France–(BUSINESS WIRE)–The approval obtained by the EIB is for a new credit facility of 40 million euros<\/b>\n<\/p>\n

<\/a><\/p>\n

\nThe new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB<\/b>\n<\/p>\n

\n30 million euros of the credit facility could be drawn in Q4 2022, and the disbursement of the remaining 10 million euros is subject to conditions that are expected to be met in 2023<\/b>\n<\/p>\n

\nEach tranche of the new credit facility will be reimbursed 5 years after drawdown<\/b>\n<\/p>\n

\nThe signature of the new EIB credit facility is expected in a few weeks after finalization of the legal documentation<\/b>\n<\/p>\n

\nNew EIB financing extends MedinCell\u2019s cash visibility until at least the first quarter 2024<\/b>\n<\/p>\n

\nAs the commercialization of the first treatment based on MedinCell\u2019s breakthrough technology is expected in 2023, the European Investment Bank reiterates its support to the French company with a new financing package of 40 million euros.\n<\/p>\n

\nAccess the full press release here<\/a>\n<\/p>\n

\nAbout MedinCell<\/b>\n<\/p>\n

\nMedinCell is a pharmaceutical company at premarketing stage that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO\u00ae<\/sup> technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO\u00ae<\/sup> technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. MedinCell collaborate with tier one pharmaceuticals companies and foundations to improve Global Health through new therapeutic options. Based in Montpellier, MedinCell currently employs more than 150 people representing over 30 different nationalities.\n<\/p>\n

\nwww.medincell.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedinCell
\n
David Heuz\u00e9<\/strong>
Communication leader<\/strong>
david.heuze@medincell.com<\/a>
+33 (0)6 83 25 21 86\n<\/p>\n

\nNewCap
\n
Louis-Victor Delouvrier\/Olivier Bricaud<\/strong>
Investor Relations<\/strong>
medincell@newcap.eu<\/a>
+33 (0)1 44 71 94 94\n<\/p>\n

\nNewCap
\n
Nicolas Merigeau<\/strong>
Media Relations<\/strong>
medincell@newcap.eu<\/a>
+33 (0)1 44 71 94 94\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MONTPELLIER, France–(BUSINESS WIRE)–The approval obtained by the EIB is for a new credit facility of 40 million euros The new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB 30 million euros of the credit facility could be drawn in Q4 2022, and the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47982","6":"format-standard","7":"category-industry"},"yoast_head":"\nMedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MONTPELLIER, France–(BUSINESS WIRE)–The approval obtained by the EIB is for a new credit facility of 40 million euros The new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB 30 million euros of the credit facility could be drawn in Q4 2022, and the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-05T17:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220905005397\/en\/1561497\/21\/Logo_MedinCell_registered.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB)\",\"datePublished\":\"2022-09-05T17:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/\"},\"wordCount\":356,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005397\\\/en\\\/1561497\\\/21\\\/Logo_MedinCell_registered.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/\",\"name\":\"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005397\\\/en\\\/1561497\\\/21\\\/Logo_MedinCell_registered.jpg\",\"datePublished\":\"2022-09-05T17:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005397\\\/en\\\/1561497\\\/21\\\/Logo_MedinCell_registered.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005397\\\/en\\\/1561497\\\/21\\\/Logo_MedinCell_registered.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/","og_locale":"en_US","og_type":"article","og_title":"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) - Pharma Trend","og_description":"MONTPELLIER, France–(BUSINESS WIRE)–The approval obtained by the EIB is for a new credit facility of 40 million euros The new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB 30 million euros of the credit facility could be drawn in Q4 2022, and the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-05T17:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220905005397\/en\/1561497\/21\/Logo_MedinCell_registered.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB)","datePublished":"2022-09-05T17:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/"},"wordCount":356,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005397\/en\/1561497\/21\/Logo_MedinCell_registered.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/","url":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/","name":"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005397\/en\/1561497\/21\/Logo_MedinCell_registered.jpg","datePublished":"2022-09-05T17:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220905005397\/en\/1561497\/21\/Logo_MedinCell_registered.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220905005397\/en\/1561497\/21\/Logo_MedinCell_registered.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medincell-secures-additional-20-million-euros-financing-with-the-european-investment-bank-eib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB)"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47982"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47982\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}